Reply: Cisplatin-associated aortic thrombosis: a review of cases reported to the FDA adverse event reporting system

Cameron, A. C., Neves, K. B. , White, J., Touyz, R. M. and Lang, N. N. (2021) Reply: Cisplatin-associated aortic thrombosis: a review of cases reported to the FDA adverse event reporting system. JACC: CardioOncology, 3(1), p. 166. (doi: 10.1016/j.jaccao.2021.01.005)

[img] Text
233800.pdf - Published Version
Available under License Creative Commons Attribution.

78kB

Abstract

No abstract available.

Item Type:Articles (Letter)
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Lang, Dr Ninian and White, Dr Jeffery and Cameron, Dr Alan and Touyz, Professor Rhian and Neves, Dr Karla
Authors: Cameron, A. C., Neves, K. B., White, J., Touyz, R. M., and Lang, N. N.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:JACC: CardioOncology
Publisher:Elsevier
ISSN:2666-0873
ISSN (Online):2666-0873
Published Online:16 March 2021
Copyright Holders:Copyright © 2021 The Authors
First Published:First published in JACC: CardioOncology 3(1): 166
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record